CIA
CLB icon

CSat Investment Advisory’s Core Laboratories CLB Stock Holding History

CSat Investment Advisory’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-171
Closed -$2K – 1112
2020
Q1 		$2K Buy
171
+38
+29% +$1.06K ﹤0.01% 1060
2019
Q4 		$5K Buy
133
+16
+14% +$719 ﹤0.01% 1063
2019
Q3 		$5K Buy
117
+16
+16% +$744 ﹤0.01% 1038
2019
Q2 		$5K Buy
+101
New +$5.92K ﹤0.01% 1045

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

CSat Investment Advisory's CLB Position: Q2 2020 in Review

CSat Investment Advisory sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 171 shares — an estimated $2K sold.

CSat Investment Advisory first reported a position in CLB in Q2 2019 and held it in 4 quarters. The position peaked at $5K in Q4 2019. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • CSat Investment Advisory reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 171 Core Laboratories shares in Q2 2020, an estimated $2K.
  • CSat Investment Advisory first reported a position in Core Laboratories in Q2 2019 and held it in 4 quarters.
  • CSat Investment Advisory's Core Laboratories position peaked at $5K in Q4 2019.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on CSat Investment Advisory's 13F filing for Q2 2020, filed 7 Aug 2020.